Trials / Completed
CompletedNCT03335761
InterStim® Amplitude Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This feasibility study will explore the effects of three different InterStim amplitude settings on overactive bladder symptoms (OAB).
Detailed description
This is a prospective, randomized, multicenter, single-blinded study to explore the efficacy and quality of life (QoL) of 3 different amplitude settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | InterStim Therapy | Device Programming |
Timeline
- Start date
- 2018-02-27
- Primary completion
- 2019-11-06
- Completion
- 2019-11-06
- First posted
- 2017-11-08
- Last updated
- 2021-01-08
- Results posted
- 2021-01-08
Locations
18 sites across 7 countries: United States, Belgium, Canada, France, Italy, Netherlands, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03335761. Inclusion in this directory is not an endorsement.